Literature DB >> 8786014

Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM.

A Maran1, J Lomas, I A Macdonald, S A Amiel.   

Abstract

Severe hypoglycaemia with cognitive dysfunction is 3 times more common in intensively, rather than conventionally, treated insulin-dependent diabetes mellitus (IDDM). To investigate the effect of diabetes control on higher brain function during acute hypoglycaemia, we studied one of the earliest detectable changes in cognitive function, i.e. the four-choice reaction time, and symptomatic and hormonal responses during euglycaemic and hypoglycaemic clamping in human subjects. There were no changes in symptoms or counterregulatory hormones and four-choice reaction time was stable during 220 min of euglycaemic insulin clamping in five men with IDDM, with a coefficient of variation of less than 2.2% (1% for accuracy) for the cognitive function test. During stepped hypoglycaemic clamping however, hormonal responses and subjective awareness of hypoglycaemia occurred in all groups but started at much lower blood glucose concentrations in eight intensively-treated diabetic subjects (Group 1) than in ten conventionally-treated (Group 2) or in eight non-diabetic subjects (Group 3). For example, for adrenaline, plasma glucose thresholds were 2.7 +/- 0.2 vs 3.4 +/- 0.2 and 3.2 +/- 0.1 mmol/l, respectively, p < 0.05, Group 1 vs Groups 2 or 3 and for subjective awareness of hypoglycaemia 2.3 +/- 0.2 vs 3.0 +/- 0.1 and 3.2 +/- 0.1 mmol/l, p < or = 0.003), as in previous studies. In contrast, deterioration in reaction time occurred at 3.2 +/- 0.3, 3.2 +/- 0.2 and 3.0 +/- 0.2 mmol/l, respectively (p = NS), thus occurring at higher glucose levels than subjective awareness in the intensively-treated subjects only. The altered hierarchy of responses to hypoglycaemia in well-controlled intensively-treated diabetes explains the increased risk of severe hypoglycaemia without warning seen in such patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8786014     DOI: 10.1007/bf00400601

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

2.  Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus.

Authors:  B Widom; D C Simonson
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

3.  Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus.

Authors:  S A Amiel; W V Tamborlane; D C Simonson; R S Sherwin
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

4.  Reversibility of unawareness of hypoglycemia in patients with insulinomas.

Authors:  A Mitrakou; C Fanelli; T Veneman; G Perriello; S Calderone; D Platanisiotis; A Rambotti; S Raptis; P Brunetti; P Cryer
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

5.  Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans.

Authors:  S A Amiel; D C Simonson; W V Tamborlane; R A DeFronzo; R S Sherwin
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

6.  Influence of sympathetic nervous system on hypoglycaemic warning symptoms.

Authors:  S R Heller; I A Macdonald; M Herbert; R B Tattersall
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

7.  Effects of previous glycaemic control on the onset and magnitude of cognitive dysfunction during hypoglycaemia in type 1 (insulin-dependent) diabetic patients.

Authors:  D Ziegler; A Hübinger; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

8.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.

Authors:  S R Heller; P E Cryer
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

10.  Protection by lactate of cerebral function during hypoglycaemia.

Authors:  A Maran; I Cranston; J Lomas; I Macdonald; S A Amiel
Journal:  Lancet       Date:  1994-01-01       Impact factor: 79.321

View more
  25 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 2.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman
Journal:  Diabetes Technol Ther       Date:  2018-12-21       Impact factor: 6.118

Review 5.  Influence of exercise on skill proficiency in soccer.

Authors:  Mark Russell; Michael Kingsley
Journal:  Sports Med       Date:  2011-07-01       Impact factor: 11.136

Review 6.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

Review 7.  Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.

Authors:  Yee-Seun Cheah; Stephanie A Amiel
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

8.  HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.

Authors:  Lutz Heinemann; Dorothee Deiss; Norbert Hermanns; Claudia Graham; Matthias Kaltheuner; Andreas Liebl; David Price
Journal:  J Diabetes Sci Technol       Date:  2015-03-09

9.  Hypoglycemia: from the laboratory to the clinic.

Authors:  Stephanie A Amiel
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 17.152

10.  Effects of acute insulin-induced hypoglycaemia on psychomotor function: people with type 1 diabetes are less affected than non-diabetic adults.

Authors:  J Geddes; I J Deary; B M Frier
Journal:  Diabetologia       Date:  2008-08-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.